InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Ryan Charles S.. Director active across 1 company, notably Quince Therapeutics, Inc.. In total, 2 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 20 August 2024. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations